GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Short-Term Debt & Capital Lease Obligation

ChemoMetec AS (FRA:CHY) Short-Term Debt & Capital Lease Obligation : €0.43 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is ChemoMetec AS Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. ChemoMetec AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.43 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. ChemoMetec AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.13 Mil.

ChemoMetec AS Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for ChemoMetec AS's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Short-Term Debt & Capital Lease Obligation Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.19 0.26 0.47 0.43

ChemoMetec AS Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.46 0.47 0.45 0.43

ChemoMetec AS Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

ChemoMetec AS Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » Short-Term Debt & Capital Lease Obligation
Comparable Companies
OCSE:SMSMED OCSE:VIRO OCSE:EMBLA OCSE:GN OCSE:AMBU B ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA DXCM STE XSWX:SOON ZBH PODD SHSE:688271 LSE:SN.
Traded in Other Exchanges
CHEMMc:UK 0DZ0:UK CHEMM:Denmark
Address
Gydevang 43, Allerod, DNK, 3450
Website
https://www.chemometec.com
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.